+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Terbinafine"

Onychomycosis Global Market Report 2024 - Product Thumbnail Image

Onychomycosis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Onychomycosis Treatment Global Market Report 2024 - Product Thumbnail Image

Onychomycosis Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
Onychomycosis - Pipeline Insight, 2024 - Product Thumbnail Image

Onychomycosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
Tinea Pedis - Pipeline Insight, 2024 - Product Thumbnail Image

Tinea Pedis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Anti-Infectious Disease Drugs Markets in China - Product Thumbnail Image

Anti-Infectious Disease Drugs Markets in China

  • Report
  • July 2023
  • 229 Pages
  • China
From
Loading Indicator

Terbinafine is an antifungal drug used to treat a variety of fungal infections, including those caused by dermatophytes, yeasts, and molds. It is commonly used to treat skin and nail infections, such as athlete's foot, jock itch, and ringworm. It is also used to treat fungal infections of the scalp, fingernails, and toenails. Terbinafine is a member of the allylamine class of antifungal drugs, which are used to treat a variety of fungal infections. Terbinafine is a widely used antifungal drug in the infectious diseases drugs market. It is used to treat a variety of fungal infections, including those caused by dermatophytes, yeasts, and molds. It is generally well tolerated and has a low risk of side effects. Some companies in the Terbinafine market include Novartis, Pfizer, Merck, and GlaxoSmithKline. Show Less Read more